Wyeth Calls For End To Discovery In Prempro MDL

Law360, New York (May 20, 2008, 12:00 AM EDT) -- Wyeth Pharmaceuticals Inc. has urged a federal judge to set a deadline for generic discovery in the multidistrict proceedings over its hormone pills, saying the speedy resolution of the litigation required an end to the drawn-out pretrial phase.

Responding to requests by the U.S. District Court for the Eastern District of Arkansas to propose a process to resolve the massive litigation over Prempro and Premarin, Wyeth said the setting of a target date for the completion of the first phase of discovery – now in its...
To view the full article, register now.